Cardiovascular morbidity and mortality in the Losartan intervention for endpoint reduction in hypertension study (LIFE):a randomised trial against atenolol - Dahlöf, B; Devereux, RB; Kjeldsen, SE; LIFE study group (Lancet, 2002)